Search

Your search keyword '"Rajpal, Rajesh K."' showing total 26 results
Start Over Author "Rajpal, Rajesh K." Search Limiters Peer Reviewed
26 results on '"Rajpal, Rajesh K."'

4. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment

Author

Milner, Mark S., Beckman, Kenneth A., Luchs, Jodi I., Allen, Quentin B., Awdeh, Richard M., Berdahl, John, Boland, Thomas S., Buznego, Carlos, Gira, Joseph P., Goldberg, Damien F., Goldman, David, Goyal, Raj K., Jackson, Mitchell A., Katz, James, Kim, Terry, Majmudar, Parag A., Malhotra, Ranjan P., McDonald, Marguerite B., Rajpal, Rajesh K., Raviv, Tal, Rowen, Sheri, Shamie, Neda, Solomon, Jonathan D., Stonecipher, Karl, Tauber, Shachar, Trattler, William, Walter, Keith A., Waring, George O., IV, Weinstock, Robert J., Wiley, William F., and Yeu, Elizabeth

Published
2017
Full Text
View/download PDF

7. Addendum

Author

Hersh, Peter S., primary, Stulting, R. Doyle, additional, Muller, David, additional, Durrie, Daniel S., additional, and Rajpal, Rajesh K., additional

Published
2018
Full Text
View/download PDF

9. U.S. Multicenter Clinical Trial of Corneal Collagen Crosslinking for Treatment of Corneal Ectasia after Refractive Surgery

Author

Hersh, Peter S., primary, Stulting, R. Doyle, additional, Muller, David, additional, Durrie, Daniel S., additional, Rajpal, Rajesh K., additional, Binder, Perry S., additional, Donnenfeld, Eric D., additional, Durrie, Daniel, additional, Hardten, David, additional, Hersh, Peter, additional, Price, Francis, additional, Randleman, J. Bradley, additional, Schanzlin, David, additional, Stark, Walter, additional, Trattler, William, additional, and Trokel, Steven, additional

Published
2017
Full Text
View/download PDF

10. United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment

Author

Hersh, Peter S., primary, Stulting, R. Doyle, additional, Muller, David, additional, Durrie, Daniel S., additional, Rajpal, Rajesh K., additional, Binder, Perry S., additional, Donnenfeld, Eric D., additional, Durrie, Daniel, additional, Hardten, David, additional, Hersh, Peter, additional, Price, Francis, additional, Schanzlin, David, additional, Stark, Walter, additional, Trattler, William, additional, and Trokel, Steven, additional

Published
2017
Full Text
View/download PDF

11. Dysfunctional tear syndrome

Author

Milner, Mark S., primary, Beckman, Kenneth A., additional, Luchs, Jodi I., additional, Allen, Quentin B., additional, Awdeh, Richard M., additional, Berdahl, John, additional, Boland, Thomas S., additional, Buznego, Carlos, additional, Gira, Joseph P., additional, Goldberg, Damien F., additional, Goldman, David, additional, Goyal, Raj K., additional, Jackson, Mitchell A., additional, Katz, James, additional, Kim, Terry, additional, Majmudar, Parag A., additional, Malhotra, Ranjan P., additional, McDonald, Marguerite B., additional, Rajpal, Rajesh K., additional, Raviv, Tal, additional, Rowen, Sheri, additional, Shamie, Neda, additional, Solomon, Jonathan D., additional, Stonecipher, Karl, additional, Tauber, Shachar, additional, Trattler, William, additional, Walter, Keith A., additional, Waring, George O., additional, Weinstock, Robert J., additional, Wiley, William F., additional, and Yeu, Elizabeth, additional

Published
2017
Full Text
View/download PDF

12. How to see clearly before eye surgery

Author

RAJPAL, RAJESH K.

Subjects
Health care industry -- Services, Vision disorders -- Services, Lasers in ophthalmology -- Services, Business, Business, regional
Abstract

It is important to remember that in laser vision correction, as in any medical procedure, patients are the top priority. Marketing has promoted laser vision correction as a safe, technology-driven [...]

Published
1999

13. Tips for tackling conjunctivitis: how one practice uses diagnostic test to manage signs, symptoms in allergy season

Author

Rajpal, Rajesh K.

Subjects
Conjunctivitis -- Diagnosis -- Care and treatment, Allergic reaction -- Diagnosis -- Care and treatment, Allergy -- Diagnosis -- Care and treatment, Health
Abstract

AS CLINICIANS AT A REFERRAL cornea practice, my colleagues and I treat many patients who present with red eye. During allergy season, when allergic conjunctivitis is more prevalent, it is [...]

Published
2013

24. Patient is most aspect of any procedure.

Author

Rajpal, Rajesh K.

Abstract

Discusses the importance of considering the desired services by the patients in performing refractive surgery. Interest of patients on refractive surgery; Different procedures for refractive surgery; Commonly used procedures; Recommendations in the use of excimer laser in the United States; Factors influencing a patient's decision to undergo refractive surgery.

Published
1994

25. New artificial tear benefits patients with dry eye.

Author

Rajpal, Rajesh K.

Subjects
*OPHTHALMOLOGY, *TREATMENT of eye diseases, TREATMENT of dry eye syndromes
Abstract

The article focuses on the study which examines the effectiveness of Allergan Inc.'s Optive in the treatment of dry eye disease. During the 2008 World Ophthalmology Congress, Rajesh K. Rajpal explains that Optive, with its carboxymethylcellulose, glycerin and a preservative, is more applicable to patients with dry eye disease. When administered to these patients, the study reveals that they have shown significant improvements in objective measures of dry eye disease.

Published
2008

26. Innovations in topical ocular corticosteroid therapy for the management of postoperative ocular inflammation and pain.

Author

Salinger CL, Gaynes BI, and Rajpal RK

Subjects
Administration, Topical, Adult, Aged, Aged, 80 and over, Eye Diseases epidemiology, Female, Humans, Male, Middle Aged, Ophthalmic Solutions administration & dosage, United States, Anti-Allergic Agents administration & dosage, Eye Diseases complications, Eye Diseases surgery, Eye Pain drug therapy, Inflammation drug therapy, Loteprednol Etabonate administration & dosage, Postoperative Complications drug therapy
Abstract

Topical ophthalmic corticosteroids are of clinical benefit in the management of pain and inflammation after ocular surgery; however, their use can be associated with class-associated adverse events (AEs) and limited bioavailability. Selection of an appropriate topical corticosteroid depends on drug-specific variables such as AE profile, efficacy, potency, dosing, patient-specific administration needs, and formulation properties aimed at minimizing precorneal drug loss, increasing ocular surface drug residence time, and maximizing drug delivery to the anterior tissues. Recently, strategies for improving ocular penetration of ophthalmic formulations have included use of mucoadhesive formulations (ie, polycarbophil-containing gels) and drug particle size reduction, enabling faster drug dissolution and therefore increased bioavailability and penetration. Loteprednol etabonate (LE) is a carbon-20 ester corticosteroid developed through retrometabolic drug design with potent anti-inflammatory effects and a reduced propensity for eliciting corticosteroid class AEs. This drug has been formulated for topical ophthalmic use after surgery as 0.5% and 1% suspensions, a 0.5% ointment, and a 0.5% gel. Preclinical and clinical data for a new 0.38% LE gel will be reviewed demonstrating that reducing the drug particle size to the nanometer range in diameter provides effective ocular tissue penetration and resolution of pain and inflammation despite a reduced drug concentration (0.38%) and dosing frequency.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results